TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Inspire Medical Systems ( (INSP) ) has shared an update.
On November 6, 2025, Inspire Medical Systems announced its plan to release a significant portion of its valuation allowance on U.S. deferred tax assets in the fourth quarter of fiscal 2025. This move is expected to result in an income tax benefit of $90 million to $100 million, potentially increasing diluted earnings per share by $3.00 to $3.30, impacting the company’s financial performance positively.
The most recent analyst rating on (INSP) stock is a Buy with a $94.00 price target. To see the full list of analyst forecasts on Inspire Medical Systems stock, see the INSP Stock Forecast page.
Spark’s Take on INSP Stock
According to Spark, TipRanks’ AI Analyst, INSP is a Outperform.
Inspire Medical Systems shows strong financial performance and positive earnings call highlights, including revenue growth and improved margins. However, technical indicators suggest a bearish trend, and the stock’s high P/E ratio indicates overvaluation. These factors combine to give the stock a moderate overall score.
To see Spark’s full report on INSP stock, click here.
More about Inspire Medical Systems
Inspire Medical Systems operates in the medical technology industry, focusing on developing innovative solutions for sleep apnea treatment.
Average Trading Volume: 1,087,559
Technical Sentiment Signal: Sell
Current Market Cap: $2.51B
Learn more about INSP stock on TipRanks’ Stock Analysis page.